December 16, 2013 Dana-Farber/Harvard Cancer Center (DF/HCC) encourages and supports the development of scientific collaborations among Center members that promote new... | [more]
Welcome to Dana-Farber/Harvard Cancer CenterDana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.
Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal -- to find new and innovative ways to combat cancer.
- Seminars in Oncology: "ALK and MYCN - Axes of Targeted Therapy in Neuroblastoma" Posted: 12-11-13
- Seminars in Oncology: "Genome Regulation by Long Noncoding RNAs" Posted: 12-04-13
- Cancer Prognostic Resources website launched Posted: 12-04-13
Latest Cancer News
December 16, 2013 The DF/HCC Menís Collaborative to Cure Womenís Cancers is an unprecedented partnership providing a vehicle for men to come together as a unified force to... | [more]
October 3, 2013Internationally recognized cancer biology and genetics researcher Pier Paolo Pandolfi, MD, PhD, was recently appointed the new Director of the BIDMC Cancer... | [more]